Literature DB >> 25036569

Immune complex-mediated autoimmunity in a patient With Smith-Magenis syndrome (del 17p11.2).

Jianying Yang1, Settara C Chandrasekharappa, Thierry Vilboux, Ann C M Smith, Erik J Peterson.   

Abstract

Smith-Magenis syndrome (SMS) is a sporadic congenital disorder involving multiple organ systems caused by chromosome 17p11.2 deletions. Smith-Magenis syndrome features craniofacial and skeletal anomalies, cognitive impairment, and neurobehavioral abnormalities. In addition, some SMS patients may exhibit hypogammaglobulinemia. We report the first case of SMS-associated autoimmunity in a woman who presented with adult onset of multiple autoimmune disorders, including systemic lupus erythematosus, antiphospholipid antibody syndrome, and autoimmune hepatitis. Molecular analysis using single-nucleotide polymorphism array confirmed a de novo 3.8-Mb deletion (breakpoints, chr17: 16,660,721-20,417,975), resulting in haploinsufficiency for TACI (transmembrane activator and CAML interactor). Our data are consistent with potential loss of function for the BAFF (B cell-activating factor) receptor TACI as a contributing factor to human autoimmune phenomena.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25036569      PMCID: PMC4201030          DOI: 10.1097/RHU.0000000000000118

Source DB:  PubMed          Journal:  J Clin Rheumatol        ISSN: 1076-1608            Impact factor:   3.517


  15 in total

1.  Regulation of the T-independent humoral response by TACI.

Authors:  G U von Bülow; J M van Deursen; R J Bram
Journal:  Immunity       Date:  2001-05       Impact factor: 31.745

2.  Whole genome genotyping technologies on the BeadArray platform.

Authors:  Frank J Steemers; Kevin L Gunderson
Journal:  Biotechnol J       Date:  2007-01       Impact factor: 4.677

3.  Molecular analyses of 17p11.2 deletions in 62 Smith-Magenis syndrome patients.

Authors:  R C Juyal; L E Figuera; X Hauge; S H Elsea; J R Lupski; F Greenberg; A Baldini; P I Patel
Journal:  Am J Hum Genet       Date:  1996-05       Impact factor: 11.025

4.  Transmembrane activator and CAML interactor (TACI) haploinsufficiency results in B-cell dysfunction in patients with Smith-Magenis syndrome.

Authors:  Javier Chinen; Monica Martinez-Gallo; Wenli Gu; Montserrat Cols; Andrea Cerutti; Lin Radigan; Li Zhang; Lorraine Potocki; Marjorie Withers; James R Lupski; Charlotte Cunningham-Rundles
Journal:  J Allergy Clin Immunol       Date:  2011-04-22       Impact factor: 10.793

5.  Interstitial deletion of (17)(p11.2p11.2) in nine patients.

Authors:  A C Smith; L McGavran; J Robinson; G Waldstein; J Macfarlane; J Zonona; J Reiss; M Lahr; L Allen; E Magenis
Journal:  Am J Med Genet       Date:  1986-07

6.  TACI is mutant in common variable immunodeficiency and IgA deficiency.

Authors:  Emanuela Castigli; Stephen A Wilson; Lilit Garibyan; Rima Rachid; Francisco Bonilla; Lynda Schneider; Raif S Geha
Journal:  Nat Genet       Date:  2005-07-10       Impact factor: 38.330

7.  Activation and accumulation of B cells in TACI-deficient mice.

Authors:  M Yan; H Wang; B Chan; M Roose-Girma; S Erickson; T Baker; D Tumas; I S Grewal; V M Dixit
Journal:  Nat Immunol       Date:  2001-07       Impact factor: 25.606

8.  Loss of TACI causes fatal lymphoproliferation and autoimmunity, establishing TACI as an inhibitory BLyS receptor.

Authors:  Dhaya Seshasayee; Patricia Valdez; Minhong Yan; Vishva M Dixit; Daniel Tumas; Iqbal S Grewal
Journal:  Immunity       Date:  2003-02       Impact factor: 31.745

9.  Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations.

Authors:  F Mackay; S A Woodcock; P Lawton; C Ambrose; M Baetscher; P Schneider; J Tschopp; J L Browning
Journal:  J Exp Med       Date:  1999-12-06       Impact factor: 14.307

10.  TACI and BAFF-R mediate isotype switching in B cells.

Authors:  Emanuela Castigli; Stephen A Wilson; Sumi Scott; Fatma Dedeoglu; Shengli Xu; Kong-Peng Lam; Richard J Bram; Haifa Jabara; Raif S Geha
Journal:  J Exp Med       Date:  2005-01-03       Impact factor: 14.307

View more
  2 in total

1.  Systemic lupus erythematosus as a genetic disease.

Authors:  Isaac T W Harley; Amr H Sawalha
Journal:  Clin Immunol       Date:  2022-02-09       Impact factor: 10.190

Review 2.  Polygenic autoimmune disease risk alleles impacting B cell tolerance act in concert across shared molecular networks in mouse and in humans.

Authors:  Isaac T W Harley; Kristen Allison; R Hal Scofield
Journal:  Front Immunol       Date:  2022-08-24       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.